<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="urology" lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">JOHS</journal-id>
<journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
<journal-title-group>
<journal-title>Journal of HealthCare Sciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">2231-2196</issn>
<issn pub-type="opub">0975-5241</issn>
<publisher>
<publisher-name>Radiance Research Academy</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">113</article-id>
<article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2022.21120</article-id>
<article-id pub-id-type="doi-url"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Urology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Overview of Oral Chemolysis Types and Its Effectiveness in Treating Kidney Stones
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alqahtani</surname>
<given-names>Ali</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faydh</surname>
<given-names>Jamal</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thobaiti</surname>
<given-names>Talal AL</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Algamdi</surname>
<given-names>Mohannd</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alyami</surname>
<given-names>Safar</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qaed</surname>
<given-names>Mohammed Al</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Albaqami</surname>
<given-names>Sultan</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alamri</surname>
<given-names>Abdulrahman</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alamri</surname>
<given-names>Abdulrahim</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alsarah</surname>
<given-names>Aouss</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alabdulwahab</surname>
<given-names>Abdulelah</given-names>
</name>
</contrib>
</contrib-group>
<pub-date pub-type="ppub">
<day>24</day>
<month>11</month>
<year>2022</year>
</pub-date>
<volume>2</volume>
<issue>11</issue>
<fpage>463</fpage>
<lpage>467</lpage>
<permissions>
<copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
<copyright-year>2009</copyright-year>
<license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<p>One of the most often diagnosed urological disorders is kidney stones with a prevalence which varies between 5% and 10% globally. In 1924, Crowell presented the first description of stone disintegration by direct irrigation. Since then, chemolysis-based dissolution therapy has been applied for the treatment of kidney stones in both primary and adjuvant settings, with different degrees of success. Depending on the type of stone, several chemolysis techniques can be applied. It has been suggested that d-penicillamine, tromethamine-E or tiopronin, and N-acetylcysteine can dissolve cystine stones. While phosphate stones are known to dissolve in acidic solutions. Renacidin and Suby G are two of the most common compounds used for chemolysis. Chemolysis can be utilized as a stand-alone therapy or as an adjuvant to shock wave lithotripsy, percutaneous nephrolithotomy, or open stone removal. The purpose of this research is to review the available information about overview of oral chemolysis types and its effectiveness in treating kidney stones. Oral chemolysis is a safe and effective treatment modality for patients with kidney stones. However, oral chemolysis is infrequently used despite the potential benefit of avoiding stone surgery with all its potential risks. The absence of trustworthy predictors of its outcome and the scarcity of high-quality data on its effectiveness are two factors contributing to its restricted utilization further clinical trial-based research is therefore needed to elaborately study the efficacy profile of oral chemolysis on various stone sizes and types.
</p>
</abstract>
<kwd-group>
<kwd>kidney stones</kwd>
<kwd> nephrolithiasis</kwd>
<kwd> oral chemolysis</kwd>
<kwd> medical treatment</kwd>
<kwd> Renacidin</kwd>
<kwd> Suby G</kwd>
</kwd-group>
</article-meta>
</front>
</article>